The BioResource is crucial for scientists working to understand the links between genes and disease, and developing precision treatments. Precision medicine, sometimes known as ‘personalised medicine’, is an innovative approach to disease prevention and treatment that takes into account differences in people’s genes, environments and lifestyles.

Fibromyalgia is a long-term condition that causes pain all over the body. Some estimates suggest nearly 1 in 20 people may be affected by fibromyalgia to some degree.

Volunteers who have donated samples to the NIHR BioResource are already contributing to the quicker development of personalised therapeutic treatments for fibromyalgia through a study led by Dr. Frances Williams, Reader in Genetic Epidemiology, Division of Genetics & Molecular Medicine at King’s College London, and Consultant Rheumatologist at Guy’s and St Thomas’ NHS Foundation Trust.

Dr Williams applied to the BioResource to recruit people affected by fibromyalgia for her ‘FIBROGENE’ project.The project focuses on the identification of genes responsible for fibromyalgia, with the ultimate goal of identifying individuals at particularly high risk of fibromyalgia. A better understanding of the genes related to fibromyalgia will also facilitate the development of precision treatments for people suffering with this disease.

doctor and nurse

Contact

To find out more about this study please contact the BioResource team at gsttbioresource@kcl.ac.uk